Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Case report details rare basal cell carcinoma on patient's finger

Basal cell carcinoma is the most prevalent form of skin cancer, typically developing on sun-exposed areas like the face and neck.

26 Jun 2026

Welbeck Health Partners adopts OMED Health’s home-based SIBO testing pathway across its network

OMED Health ("OMED"), part of Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, and Welbeck Health Partners ("Welbeck"), one of the UK's largest specialist outpatient healthcare providers, today announced that Welbeck has adopted OMED Health's home-based Small Intestinal Bacterial Overgrowth (SIBO) breath-testing pathway. The roll out across Welbeck's network follows a three-month evaluation where the pathway was assessed for performance and impact on standard of care.

From Welbeck Health Partners 25 Jun 2026

Most IVF add-ons lack evidence of fertility benefits

There is a lack of evidence to suggest the majority of in vitro fertilization (IVF) add-ons improve fertility in patients undergoing IVF, according to a systematic review and meta-analysis published in The Lancet Obstetrics, Gynaecology, & Women's Health journal.

24 Jun 2026

AI image-based risk scores enable dynamic breast cancer assessment

Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer derived from screening mammograms evolve over time and differ between women who develop cancer and those who do not, opening the door to a new era of dynamic breast cancer risk assessment.

23 Jun 2026

Skin barrier monitoring predicts necrosis after skin flap surgery

Random-pattern skin flaps (RPSFs) receive blood mainly from small subcutaneous vessels rather than a defined axial vessel, leaving them vulnerable to ischemia and hypoxia after surgery.

23 Jun 2026

Review outlines how donor imaging improves liver transplantation outcomes

Liver transplantation often depends on decisions made under pressure. In deceased donation, teams must quickly judge whether a liver is suitable, whether fat accumulation could threaten graft function, and whether unexpected vascular anatomy may complicate procurement or implantation.

22 Jun 2026

AI imaging technique detects early endometrial cancer with high accuracy

Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing up to 3% annually.

18 Jun 2026

Leica Biosystems launches AI-powered digital pathology solution in Europe, Middle East and Africa

With the Aperio GT Elite, Leica Biosystems advances digital pathology in EMEA, combining high-throughput scanning with innovative AI quality control features.

From Leica Biosystems 16 Jun 2026

Dual-target CAR T therapy triggers broad immune response in brain cancer

Dual-target CAR T cell therapy for recurrent glioblastoma (GBM), delivered directly into the cerebrospinal fluid (CSF), triggers a broad immune response, with natural killer (NK) cell activation linked to better patient outcomes and longer overall survival.

15 Jun 2026

Viral DNA blood test accurately gauges post-surgery cancer recovery success

A new study by investigators from Mass General Brigham Cancer Institute found that an ultrasensitive blood test called HPV-DeepSeek could help identify which people with HPV-associated head and neck cancer still had cancer cells in their bodies after surgery and may benefit the most from additional treatments. Their results are published in Science Translational Medicine.

11 Jun 2026

Researchers isolate intact tumor microRNAs using antibody-conjugated nanowires

A research team in Japan has developed an efficient and minimally invasive cancer detection device that uses high-performance zinc oxide nanowires to selectively capture extracellular vesicles (EVs) from bodily fluids.

11 Jun 2026

Real-time 3D ultrasound in augmented reality helps novices perform like experts

Interpreting medical ultrasound images is a difficult task, requiring a technician to look at 2D images and mentally arrange them into a 3D representation of what the tissue looks like.

10 Jun 2026

Machine learning model filters out the biological noise in liquid biopsy samples

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to their patients' tumors.

9 Jun 2026

New non-invasive tool lowers cancer DNA tracking threshold to 5%

Blood tests have proved to be a promising tool for detecting and monitoring cancer. Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have now developed a new method that makes it possible to analyze samples containing as little as 5 per cent cancer DNA in the blood, compared with the 15–20 per cent required today. This method could lead to better cancer care and improved monitoring of tumor progression.

9 Jun 2026

Defective HIV copies explain persistent viral traces during treatment

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives.

8 Jun 2026

Biopsy-driven treatment strategy improves clinical outcomes in psoriatic arthritis

The management of psoriatic arthritis is increasingly focused on the early identification of clinical, immunological, and tissue-based phenotypes predictive of therapeutic response.

5 Jun 2026

New AI tool cuts breast cancer biopsy wait times

Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer.

2 Jun 2026

New PET tracer offers a powerful tool for kidney cancer staging

A new PET tracer targeting carbonic anhydrase IX (CAIX) has demonstrated exceptional sensitivity and high tumor-to-background contrast in detecting clear cell renal cell carcinoma (ccRCC), according to early clinical research.

1 Jun 2026

Cryoprobe improves diagnostic accuracy in transbronchial lung biopsies

In a new study published in JAMA, the diagnostic yield of transbronchial lung biopsy was significantly higher when using a cryoprobe versus forceps in a group of patients with pulmonary nodules or masses, recent lung transplant, and diffuse parenchymal lung disease.

29 May 2026

Gene test helps many breast cancer patients avoid chemotherapy

Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large international clinical trial led by UCL has found.

29 May 2026